Clinical trial
Evaluation of GW406381 in Treating Adults With Osteoarthritis Of The Knee
NCT00120900 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00120900 |
|---|---|
| Title | Evaluation of GW406381 in Treating Adults With Osteoarthritis Of The Knee |
| Official title | A Phase III, 12-week, Multicentre, Double-Blind, Double-Dummy, Randomised, Placebo - and Active Comparator - Contolled, Parallel Group Study to Investigate the Efficacy and Safety of GW406381 XXmg and YYmg Administered Orally Once Daily, in Adults With Osteoarthritis of the Knee |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Osteoarthritis, Knee |
| Intervention type | Drug |
| Interventions | GW406381 |
| Enrollment | 1,340 |
| Start date | May 1, 2005 |
| Primary completion | Sep 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Jul 19, 2005 |
| Last update posted | Jan 19, 2017 |
| Countries | Denmark, Netherlands, Norway, South Korea, Spain, Sweden |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: